Main Article Content
Hepatitis B , Virus, HBsAg, Pregnancy, Nigeria
Background: Hepatitis B Virus Hepatitis B Virus (HBV) infection is a global public health problem. It is highly endemic in Nigeria, and it is estimated that about 9-12% of the total population of Nigeria are chronic carriers of hepatitis B surface antigen. Epidemiological data on (HBV)infection among pregnant women in Nigeria are very scarce, especially in rural areas. The purpose of this study was to determine the prevalence and potential perinatal transmission among rural pregnant women in Abakaliki Nigeria.
Methods: A cross-sectional study was conducted among pregnant women accessing antenatal care at the Federal Teaching Hospital, Abakaliki. We consecutively recruited 300 pregnant women attending antenatal consultations. A pretested questionnaire was used to collect socio-demographic data and factors associated with HBV infection. The presence of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and human immunodeficiency virus (HIV) were determined using commercial test strips. A chi-square test was used for the analysis.
Results: The mean age was 31.8 (SD6.2) years. All women were married and (23.4%) were farmers while (47.0%) had secondary education. Sixteen women (5.3%) were HBsAg-positive, of whom (6.3%) were positive for HBsAg. The prevalence of HIV infection was (0.3%). Overall, (6.3%) women were co-infected with HIV and HBV. Independent correlates of HBV infection included a history of Jaundice (p = 0.046) history of sexually transmitted infections (p=0.005) and concurrent infection by HIV (p < 0.0001).
Conclusion: The prevalence of HBV infection among pregnant women in Abakaliki was intermediate. The relatively high rate of women positive to both HBsAg and HBeAg suggests that perinatal transmission of HBV might be the prevailing mode of HBV transmission in this area.
2. Okoth; Mkbttia J; Gathesen Z; Marila F. Mogo F. Esamai F. Alavi Z. Otieno Y; Iambatt H; Wanjaki N; Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr med Journal. 2006; 38(9): 485-39.
3. Kane M. Global Programme for the control of hepatitis B infection. Vaccine: 1995; 13 (supp); 544-549.
4. Akani C. I; Ojule A. C; Opurun H.C. Ejikele A.A; Seroprevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt Nigeria. The Nigerian Postgraduate Medical Journal. 2005: 12(4): 266-267
5. Abia-bassey L. N: TabiSeropositivity of B virus among Health care workers, In Calabar Nigeria. Mary Slessor Journal of Medicine 2006 6(2): 36-39.
6. Ejele O. Nwauche C.A Erabor O. The Prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta. Nigeria. Nigerian Journal of medicine: 2004; 13(2): 175-9:
7. Anya S.E; OshiD.C;Ezeoke A.C.Y. Jaundice in pregnant Nigerians. International Journal of Gynecology and Obstetrics 1999; 65(1): 59-60
8. Harry T. O; Bajani M. D. Moses A. Hepatitis B. Virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Africa Medical Journal. 1994;7(8):596-7.
9. Amazigyo U.O; Chime A. B; Hepatitis B virus infection in an urban population of Eastern Nigeria: prevalence of serological markers. East Afr Med. J. 1990; 67(8): 539-44.
10. Vildozola H; Baxil V; Canibilla E; Torres Y: Hora M.E: Ramos E: prevalence of hepatitis B infection and risk factors in two groups of pregnant adolescents related to the number of sexual partners. Rev; Gastroenteralperu. 2006; 26(3): 242- 58
11. Saders R. C; Lewis D; Dyke T; Alpers M. P. Markers of hepatitis B. infection in Tari District, southern Highlands province, Papau New Guinea P. N. G. Med. Journal. 1992; 35(3):197-207.12. Acquaye J. K; Mingle Y. A. hepatitis B Virus markers in Ghanian pregnant women. West Afr. Journal. Med. 1994; 13(3): 134 -7
13. Nelson NP, Jamieson DJ, Murphy TV. Prevention of perinatal hepatitis B virus transmission. J Pediatric Infect Dis Soc. 2014; 3 Suppl 1:S7–12.
14. Anna SF, Lok MD. Chronic hepatitis B. N Engl J Med. 2002; 346:1682–3.
15. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151(4):599–603.
16. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006;332(7537):328–36.
18. Araoye M.O. Subjects selection. In Araoye M.O (ed) Research Methodology with Statistics for Health and social sciences llorin. Nathadax publishers 2003:115-129.
19. Onakewhor, J.U.E., Offor, E., Okonofua, F.E. (2001). Maternal and neonatal sero-prevalence of Hepatitis B surface antigen (HBsAg) in Benin City. Journal of Obstetrics and Gynecology, 21 (6): 583-586.
20. Agbede, O. O., Iseniyi, J. O., Kolawole, M.O., Ojuowa, A. (2007). Risk factors and seroprevalence of hepatitis B surface antigenemia in mothers and their preschool age children in Ilorin, Nigeria. Therapy, 4(1): 67-72.
21. Harry, T.O., Bajani, M.D., Moses, A.E. (1994). Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Africa Medical Journal, 70:596-597.
22. Luka, S.A., Ibrahim, M.B., Iliya, S.N. (2008). Seroprevalence of hepatitis B surface antigen among pregnant women attending Ahmadu Bello University Teaching hospital, Zaria, Nigeria. Nigerian Journal of Parasitology, 29(1): 38-41.
23. Ndams et al., (2008) SWJ:5-8 Epidemiology of Hepatitis B infection Among Pregnant Women Muula, A.S. (2000). Tackling HIV/AIDS in Africa-another perspective. African Health, 23 (1): 5-60
24. Itoua-Ngaporo A, Sapoulou MV, Ibara JR, Iloki LH, Denis F. Prevalence of hepatitis B viral markers in a population of pregnant women in Brazzaville (Congo). J Gynecol ObstetBiolReprod (Paris). 1995; 24(5):534–6.
25. Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, Mugo F, et al. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J. 2006;83(9):485–93.
26. Makuwa M, Caron M, Souquière S, Malonga-Mouelet G, Mahé A, Kazanji M. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J ClinMicrobiol.2008; 46:754–6.
27. Nacro B, Dao B, Dahourou H, Hien F, Charpentier-Gautier L, Meda N, et al. HBs antigencarrier state in pregnant women in BoboDioulasso (Burkina Faso). Dakar Med.2000;45(2):188–90.
28. Mansour W, Bollahi MA, Hamed CT, Brichler S, Le Gal F, Ducancelle A, et al. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania. J ClinVirol. 2012; 55:12–6.
29. Candotti D, Danso K, Allain JP.Maternofetal transmission of hepatitis B virus genotype E in Ghana,
west Africa. J Gen Virol. 2007; 88:2686–95.
30. Touré-Fall AO, Dièye TN, Sall A, Diop M, Seck M, Diop S, et al. Residual risk of transmission of HIV and HBV, in Senegalese national blood bank from 2003 to 2005. TransfusClin Biol. 2009;16:439–43.
31. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med. 1999;45(8):195–8.
32. Imade GE, Sagay AS,UgwuBT, ThacherTD, FordRW. Seroprevalence of Hepatitis B and HIV infections in pregnant women in Nigeria. J Med Trop 2004;6:15-21
33. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis. B virus exposure is dependent on maternal virus load. J Infect Dis. 1994; 170:1418–23.
34. Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J. 2011; 8:12.
35. Thio CL. Hepatitis B, and human immunodeficiency virus coinfection. Hepatology. 2009;49(5Suppl): S138–45